Disease

Aortic Disease and Treatment Approaches

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 6, 2026 · JOURNAL ARTICLE

New ESC/EACTS guidelines for the management of aortic valve disease: key takeaways and implications of long-term TAVR results based on recent explant and redo-TAVR registry outcomes

Journal of Cardiothoracic Surgery

A narrative review synthesizing guideline updates and registry evidence on TAVR durability and reintervention; informs clinical decision-making but lacks original comparative effectiveness data.

Expert GuidanceAortic Disease and Treatment Approaches Cardiac Valve Diseases and Treatments Congenital Heart Disease Studies

Reported

Reintervention rate at 8 years0.3–1.7%

30-day mortality after redo-TAVR1.5–6.2%

30-day mortality after explantati…11.9–13.6%

JUL 1, 2026 · JOURNAL ARTICLE

Addressing unanswered questions in transcatheter aortic valve replacement: lifetime management, leaflet modification, and cerebral protection

Mini-invasive Surgery

A narrative review synthesizing current evidence and identifying unresolved questions in TAVR practice across three clinical domains, without presenting new primary data or trial results.

Expert GuidanceMatteo Sturla Aortic Disease and Treatment Approaches Cardiac Valve Diseases and Treatments

Reported

Age threshold for TAVR in appropr…≥70 years